TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scienta Omicron AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
159,784
|
101,288
|
66,965 |
| Financial expenses |
1,773
|
9,118
|
4,003 |
| Earnings before taxes |
29,913
|
-1,886
|
-11,758 |
| EBITDA |
36,276
|
9,767
|
-6,838 |
| Total assets |
73,027
|
64,261
|
89,695 |
| Current assets |
60,093
|
51,687
|
80,050 |
| Current liabilities |
56,395
|
56,793
|
80,015 |
| Equity capital |
14,569
|
4,429
|
5,897 |
| - share capital |
438
|
431
|
402 |
| Employees (average) |
31
|
25
|
25 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.0%
|
6.9%
|
6.6% |
| Turnover per employee |
5,154
|
4,052
|
2,679 |
| Profit as a percentage of turnover |
18.7%
|
-1.9%
|
-17.6% |
| Return on assets (ROA) |
43.4%
|
11.3%
|
-8.6% |
| Current ratio |
106.6%
|
91.0%
|
100.0% |
| Return on equity (ROE) |
205.3%
|
-42.6%
|
-199.4% |
| Change turnover |
56,670
|
29,571
|
-8,041 |
| Change turnover % |
55%
|
41%
|
-11% |
| Chg. No. of employees |
6
|
0
|
-5 |
| Chg. No. of employees % |
24%
|
0%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.